Metabolically based liver damage pathophysiology in patients with urea cycle disorders - A new hypothesis

World J Gastroenterol. 2017 Nov 28;23(44):7930-7938. doi: 10.3748/wjg.v23.i44.7930.

Abstract

The underlying pathophysiology of liver dysfunction in urea cycle disorders (UCDs) is still largely elusive. There is some evidence that the accumulation of urea cycle (UC) intermediates are toxic for hepatocyte mitochondria. It is possible that liver injury is directly caused by the toxicity of ammonia. The rarity of UCDs, the lack of checking of iron level in these patients, superficial knowledge of UC and an underestimation of the metabolic role of fumaric acid, are the main reasons that are responsible for the incomprehension of the mechanism of liver injury in patients suffering from UCDs. Owing to our routine clinical practice to screen for iron overload in severely ill neonates, with the focus on the newborns suffering from acute liver failure, we report a case of citrullinemia with neonatal liver failure and high blood parameters of iron overload. We hypothesize that the key is in the decreased-deficient fumaric acid production in the course of UC in UCDs that causes several sequentially intertwined metabolic disturbances with final result of liver iron overload. The presented hypothesis could be easily tested by examining the patients suffering from UCDs, for liver iron overload. This could be easily performed in countries with a high population and comprehensive national register for inborn errors of metabolism.

Conclusion: Providing the hypothesis is correct, neonatal liver damage in patients having UCD can be prevented by the supplementation of pregnant women with fumaric or succinic acid, prepared in the form of iron supplementation pills. After birth, liver damage in patients having UCDs can be prevented by supplementation of these patients with zinc fumarate or zinc succinylate, as well.

Keywords: Citrullinemia; Fumaric acid; Krebs’ cycle; Neonatal liver iron overload; Succinic acid; Transferrin; Urea cycle disorder; Zinc fumarate supplementation.

Publication types

  • Case Reports

MeSH terms

  • Ammonia / blood
  • Ammonia / toxicity
  • Central Nervous System / physiopathology
  • Citrullinemia / blood
  • Citrullinemia / diagnosis
  • Citrullinemia / metabolism*
  • Citrullinemia / therapy
  • Enterobacter / isolation & purification
  • Fatal Outcome
  • Hepatocytes / metabolism*
  • Humans
  • Hyperammonemia / blood
  • Hyperammonemia / diagnosis
  • Hyperammonemia / metabolism*
  • Hyperammonemia / therapy
  • Infant, Newborn
  • Lethargy / etiology
  • Lethargy / metabolism
  • Lethargy / physiopathology
  • Lethargy / therapy
  • Liver / cytology
  • Liver / metabolism
  • Liver / physiopathology*
  • Liver Diseases / etiology*
  • Liver Diseases / metabolism
  • Liver Diseases / physiopathology
  • Liver Diseases / therapy
  • Male
  • Sepsis / microbiology
  • Sepsis / therapy
  • Urea / blood
  • Urea / metabolism
  • Urea / toxicity

Substances

  • Ammonia
  • Urea